Lupe, wouldn't worry about that, success in these trials would mean a staggering rerate. Besides, the options add considerable cash to the Company meaning less or no need for CR down the track. It is already factored in given they are in the money.
- Forums
- ASX - By Stock
- Ann: Clinical Progress on IHL-216A for TBI and CTE
Lupe, wouldn't worry about that, success in these trials...
-
- There are more pages in this discussion • 106 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online